您的位置:首页>论文发表>2009
2009

李翔研究团队在《Appl Biochem Biotechnol》发表文章

副标题:

时间:2009-03-31  作者:LMB  来源:文本大小:【 |  | 】  【打印

题目: Isolation and difference in anti-Staphylococcus aureus bioactivity of curvularin derivates from fungus Eupenicillium sp. 

作者: Xie L. W., Ouyang Y. C., Zou K., Wang G.  H., Chen M. J., Sun H. M., Dai S. K. Li X. 

刊物: Appl Biochem Biotechnol , IF=1.04III区)

刊号: 2009, 159(10): 284-293. 

摘要: With the anti-microbial and anti-tumor composite screening model, bioassay-guided fractionation led to the isolation of two structurally related bioactive compounds, curvularin and αβ-dehydrocurvularin, from ethyl acetate extract of Eupenicillium sp. associated with marine sponge Axinella sp. Further study on the structure–activity relationship demonstrated that both compounds exhibited differences in bioactive profiles which are highly associated with their minor structural differences. Both curvularin and αβ-dehydrocurvularin have similar level of anti-fungal and anti-tumorous activity, while αβ-dehydrocurvularin is active against Staphylococcus aureus with a minimal inhibitory concentration of 375 μg/ml but curvularin does not. No detectable activity against Gram-negative bacteria such as Escherichia coli andPseudomonas aeruginosa exists for both compounds. It is suggested that the partial planar backbone structure, due to the conjugation of π electrons in the presence of a 3,4-double bond and the carbonyl group at position C-2 in αβ-dehydrocurvularin, acts as a key factor for the inhibition of S. aureus, a Gram-positive low G + C bacteria that are often the hospital-acquired and/or community-acquired pathogen. 

 

相关附件
相关文档
Copyright    中国科学院热带海洋生物资源与生态重点实验室    版权所有
地址:广东省广州市新港西路164号  邮编:510301   粤ICP备05007992号    粤公网安备44011502001245号
电话:020-89023101  传真:86-20-84451672  Email:liujuan@scsio.ac.cn